Matthew Heeney is an Oncology physician affiliated with Boston Children's Hospital. OpenAlex indexes 189 publications with 6,274 citations (h-index 39); ClinicalTrials.gov lists 4 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
300 Longwood Ave
Fegan 704
Boston, MA 021155724
Telephone
617-355-7700Registry record last updated 1 Aug 2019.
Clinical trials
- Serum Hepcidin Immunoassay - Laboratory to Marketplace
Sponsor: Intrinsic LifeSciences, LLC
- Dose-Finding Study of SC411 in Children With Sickle Cell Disease
Sponsor: Micelle BioPharma Inc
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Octapharma USA, Inc.Program year20255 payments$18,960openpaymentsdata.cms.gov ↗
- PFIZER INC.Program year20247 payments$10,171openpaymentsdata.cms.gov ↗
- GENZYME CORPORATIONProgram year20243 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Post-Transcriptional Genetic Silencing of <i>BCL11A</i> to Treat Sickle Cell Disease
New England Journal of Medicine
2020 - Biochemical and therapeutic effects of Omega-3 fatty acids in sickle cell disease
Complementary Therapies in Medicine
2020 - Mutations in the iron-sulfur cluster biogenesis protein HSCB cause congenital sideroblastic anemia
Journal of Clinical Investigation
2020 - The effect of iron chelation therapy on overall survival in sickle cell disease and β‐thalassemia: A systematic review
American Journal of Hematology
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Stuart Orkin, MD
Boston Children's Hospital
Jane Newburger, MD
Boston Children's Hospital
Michael Landzberg, MD
Boston Children's Hospital
Stephen Sallan, MD
Boston Children's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”